2018 Guideline for the Evaluation and Management of Bradycardia and Cardiac Conduction Delay
Published: November 06, 2018
- This guideline is intended to help clinicians manage patients with bradycardia, or symptoms associated with bradycardia or cardiac conduction system disorders, it supersedes pacemaker recommendations made in a prior guideline (2008) on device-based therapy of cardiac rhythm abnormalities.
- The guideline describes a clinical evaluation approach, offers recommendations for diagnostic testing modalities and treatments, and covers principles of shared decision making.
- The guideline also explores knowledge gaps, pertinent trials in progress, and directions for future research.
- Top Things to Know: 2018 Guideline for the Evaluation & Management of Bradycardia & Cardiac Conduction Delay
- Executive Summary: 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay
- Systematic Review: Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay
- 2017 Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
- 2017 Guideline for the Evaluation and Management of Patients With Syncope
- 2014 Guideline for the Management of Patients With Atrial Fibrillation
- 2012 Focused Update Incorporated Into the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
- 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities